Cargando…
Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series
PURPOSE: Tumor induced osteomalacia (TIO) is a rare disease of mineral metabolism, whose clinical picture is dominated by hypophosphatemia usually due to an excess of circulating FGF23 produced by small mesenchymal tumors. Data on the real prevalence of the disease are lacking, with the knowledge of...
Autores principales: | Cianferotti, Luisella, Delli Poggi, Chiara, Bertoldo, Francesco, Caffarelli, Carla, Crotti, Chiara, Gatti, Davide, Giannini, Sandro, Gonnelli, Stefano, Mazzantini, Maurizio, Ombretta, Viapiana, Sella, Stefania, Setti, Angela, Varenna, Massimo, Zucchi, Francesca, Brandi, Maria Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156492/ https://www.ncbi.nlm.nih.gov/pubmed/35381903 http://dx.doi.org/10.1007/s12020-022-03039-2 |
Ejemplares similares
-
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
por: Crotti, C., et al.
Publicado: (2022) -
Osteomalacia Is Not a Single Disease
por: Cianferotti, Luisella
Publicado: (2022) -
Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data
por: Delli Poggi, Chiara, et al.
Publicado: (2022) -
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study
por: Varenna, Massimo, et al.
Publicado: (2021) -
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study
por: Varenna, Massimo, et al.
Publicado: (2022)